Abbas MM, Xu Z, Tan LCS (2018) Epidemiology of Parkinson’s Disease-East Versus West. Mov Disord Clin Pract 5(1):14–28. https://doi.org/10.1002/mdc3.12568

Article  PubMed  Google Scholar 

Adams JL, Lizarraga KJ, Waddell EM, Myers TL, Jensen-Roberts S, Modica JS, Schneider RB (2021) Digital Technology in Movement Disorders: Updates, Applications, and Challenges. Curr Neurol Neurosci Rep 21(4):16. https://doi.org/10.1007/s11910-021-01101-6

Article  PubMed  PubMed Central  Google Scholar 

Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Schaffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB (2018) Movement disorder society criteria for clinically established early Parkinson’s disease. Mov Disord 33(10):1643–1646. https://doi.org/10.1002/mds.27431

Article  PubMed  Google Scholar 

Bergen DC, World Federation of Neurology Task Force on Neurological Services (2002) Training and distribution of neurologists worldwide. J Neurol Sci 198(1–2):3–7. https://doi.org/10.1016/s0022-510x(02)00071-0

Article  PubMed  Google Scholar 

Bhidayasiri R (2021) Will Artificial Intelligence Outperform the Clinical Neurologist in the Near Future? Yes Mov Disord Clin Pract 8(4):525–528. https://doi.org/10.1002/mdc3.13202

Article  PubMed  Google Scholar 

Bhidayasiri R, Ling H (2009) Treatment of Parkinson’s disease in Thailand: review of the literature and practical recommendations. J Med Assoc Thai 92(1):142–154

PubMed  Google Scholar 

Bhidayasiri R, Martinez-Martin P (2017) Clinical Assessments in Parkinson’s Disease: Scales and Monitoring. Int Rev Neurobiol 132:129–182. https://doi.org/10.1016/bs.irn.2017.01.001

Article  CAS  Google Scholar 

Bhidayasiri R, Trenkwalder C (2018) Getting a good night sleep? The importance of recognizing and treating nocturnal hypokinesia in Parkinson’s disease. Parkinsonism Relat Disord 50:10–18. https://doi.org/10.1016/j.parkreldis.2018.01.008

Article  PubMed  Google Scholar 

Bhidayasiri R, Saksornchai K, Kaewwilai L, Phanthumchinda K (2011a) A census of movement disorders at a Thai university hospital. J Neurol Sci 301(1–2):31–34. https://doi.org/10.1016/j.jns.2010.11.010

Article  PubMed  Google Scholar 

Bhidayasiri R, Wannachai N, Limpabandhu S, Choeytim S, Suchonwanich Y, Tananyakul S, Tharathep C, Panjapiyakul P, Srismith R, Chimabutra K, Phanthumchinda K, Asawavichienjinda T (2011b) A national registry to determine the distribution and prevalence of Parkinson’s disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson’s disease. Neuroepidemiology 37(3–4):222–230. https://doi.org/10.1159/000334440

Article  Google Scholar 

Bhidayasiri R, Brenden N, Viwattanakulvanid P, Jitkritsadakul O, Tabucanon R, Jagota P, Hojer H (2014a) Identifying gaps in knowledge about Parkinson disease among medical professionals in Thailand. Neurology 82(24):2238–2240. https://doi.org/10.1212/WNL.0000000000000515

Article  PubMed  Google Scholar 

Bhidayasiri R, Petchrutchatachart S, Pongthornseri R, Anan C, Dumnin S, Thanawattano C (2014b) Low-cost, 3-dimension, office-based inertial sensors for automated tremor assessment: technical development and experimental verification. J Parkinsons Dis 4(2):273–282. https://doi.org/10.3233/JPD-130311

Article  PubMed  Google Scholar 

Bhidayasiri R, Boonpang K, Jitkritsadakul O, Calne SM, Henriksen T, Trump S, Chaiwong S, Susang P, Boonrod N, Sringean J, van Laar T, Drent M, Chaudhuri KR (2016a) Understanding the role of the Parkinson’s disease nurse specialist in the delivery of apomorphine therpy. Parkinsonism Relat Disord 33(Suppl 1):S49–S55. https://doi.org/10.1016/j.parkreldis.2016.11.014

Article  PubMed  Google Scholar 

Bhidayasiri R, Sringean J, Anan C, Boonpang K, Thanawattano C, Ray Chaudhuri K (2016b) Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in Parkinson’s disease using wearable sensors. Parkinsonism Relat Disord 33(Suppl 1):S36–S41. https://doi.org/10.1016/j.parkreldis.2016.11.016

Article  PubMed  Google Scholar 

Bhidayasiri R, Sringean J, Taechalertpaisarn P, Thanawattano C (2016c) Capturing nighttime symptoms in Parkinson disease: Technical development and experimental verification of inertial sensors for nocturnal hypokinesia. J Rehabil Res Dev 53(4):487–498. https://doi.org/10.1682/JRRD.2015.04.0062

Article  PubMed  Google Scholar 

Bhidayasiri R, Sringean J, Thanawattano C (2016d) Sensor-based evaluation and treatment of nocturnal hypokinesia in Parkinson’s disease: An evidence-based review. Parkinsonism Relat Disord 22(Suppl 1):S127-133. https://doi.org/10.1016/j.parkreldis.2015.09.049

Article  PubMed  Google Scholar 

Bhidayasiri R, Sringean J, Chaiwong S, Anan C, Penkeaw N, Leaknok A, Boonpang K, Saksornchai K, Rattanachaisit W, Thanawattano C, Jagota P (2017) Rotigotine for nocturnal hypokinesia in Parkinson’s disease: Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor. Parkinsonism Relat Disord. https://doi.org/10.1016/j.parkreldis.2017.08.010

Article  PubMed  Google Scholar 

Bhidayasiri R, Phokaewvarangkul O, Sringean J, Martinez-Martin P, Anan C, Kantachadvanich N, Chaudhuri KR, Hattori N (2019a) Evaluation of nocturnal hypokinesia in Parkinson’s disease using a novel patient/proxy questionnaire and correlations with objective monitoring. Parkinsonism Relat Disord 61:219–223. https://doi.org/10.1016/j.parkreldis.2018.09.023

Article  PubMed  Google Scholar 

Bhidayasiri R, Suthisisung J, Sringean J, Lolekha P, Srivanichpoom P, Chairangsaris P, Mekawichai P, Petchrutchatachart S, Setthawatcharawanich S, Rattanachaisit W, Paisarnsirikul A, Boonpang K, Kantachadvanich N (2019b) Thai National Formulary 2019: Drugs used in Parkinson’s disease. Food and Drug Administration of Thailand, Bangkok

Google Scholar 

Bhidayasiri R, Phokaewvarangkul O, Sakdisornchai K, Boonpang K, Chaudhuri KR, Parsons J, Lolekha P, Chairangsaris P, Srivanitchapoom P, Benedierks S, Panyakaew P, Boonmongkol T, Thongchuam Y, Kantachadvanich N, Phumphid S, Evans AH, Viriyavejakul A, Pisarnpong A, van Laar T, Jagota P (2020a) Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson’s disease management in developing countries. Expert Rev Neurother 20(6):523–537. https://doi.org/10.1080/14737175.2020.1770598

Article  CAS  PubMed  Google Scholar 

Bhidayasiri R, Maytharakcheep S, Phumphid S, Maetzler W (2022) Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technology. J Neurol Sci 435:120197. https://doi.org/10.1016/j.jns.2022.120197

Article  PubMed  Google Scholar 

Bhidayasiri R, Sringean J, Van Le T, Lim TT, Navuth C, Phoumindr A, Aye YM, Phumphid S, Vorachit S, Veasna K, Ibrahim NM, Thit WM, Rosales RL, Le M, Tran NT (2023) Movement disorders in Indochina: Resource challenges and future solutions. J Neural Transm (vienna) 130(7):875–889. https://doi.org/10.1007/s00702-023-02662-1

Article  PubMed  Google Scholar 

Bhidayasiri R, Goetz CG (2024) Embracing the promise of artificial intelligence to improve patient care in movement disorders. In: Bhidayasiri R, Maetzler W (eds) Handbook of Digital Technologies in Movement Disorders. Academic Press, Elsevier

Bhidayasiri R, Virameteekul S, Sukoandari B, Tran TN, Lim TT (2020b) Challenges of Parkinson’s Disease Care in Southeast Asia. In: Riederer P, Laux G, Nagatsu T, Le W, Riederer C (eds) NeuroPsychopharmacotherapy. Springer International Publishing, Cham, pp 1–21. doi:https://doi.org/10.1007/978-3-319-56015-1_442-1

Bhidayasiri R, Prasertpan T, Tinazzi M (2024) Engaging multi-stakeholders to develop a great digital assistive technology that Parkinson's disease patients love, value, and use to improve motor aspects of daily living. In: Bhidayasiri R, Maetzler W (eds) Handbook of Digital Technologies in Movement Disorders. Academic Press, Elsevier

Bhidayasiri R (2020) Assistive technologies in Parkinson's disease. In: Martin CR, Preedy VR (eds) The Neuroscience of Parkinson's Disease, vol 1. Academic Press, London, pp 713–728. doi:https://doi.org/10.1016/B978-0-12-815946-0.00041-7

Birbeck GL, Meyer AC, Ogunniyi A (2015) Nervous system disorders across the life course in resource-limited settings. Nature 527(7578):S167-171. https://doi.org/10.1038/nature16031

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bloem BR, Henderson EJ, Dorsey ER, Okun MS, Okubadejo N, Chan P, Andrejack J, Darweesh SKL, Munneke M (2020) Integrated and patient-centred management of Parkinson’s disease: a network model for reshaping chronic neurological care. Lancet Neurol 19(7):623–634. https://doi.org/10.1016/S1474-4422(20)30064-8

Article  PubMed  PubMed Central  Google Scholar 

Buated W, Sriyudthsak M, Sribunruangrit N, Bhidayasiri R (2012) A low-cost intervention for improving gait in Parknson’s disease patients: A cane providing visual cues. Eur Geriatr Med 3(2):126–130. https://doi.org/10.1016/j.eurger.2012.01.006

Article  Google Scholar 

Burton A (2018) How do we fix the shortage of neurologists? Lancet Neurol 17(6):502–503. https://doi.org/10.1016/S1474-4422(18)30143-1

Article  PubMed  Google Scholar 

Busis NA, Shanafelt TD, Keran CM, Levin KH, Schwarz HB, Molano JR, Vidic TR, Kass JS, Miyasaki JM, Sloan JA, Cascino TL (2017) Burnout, career satisfaction, and well-being among US neurologists in 2016. Neurology 88(8):797–808. https://doi.org/10.1212/WNL.0000000000003640

Article  PubMed Central  Google Scholar 

Calne DB, Dubini A, Stern G (1989) Did Leonardo describe Parkinson’s disease? N Engl J Med 320(9):594. https://doi.org/10.1056/NEJM198903023200912

Article  CAS  PubMed  Google Scholar 

Cao B, Ho J (2020) WHO methods and data sources for global burden of disease estimates 2000–2019 World Health Organization, Geneva

Cilia R, Akpalu A, Sarfo FS, Cham M, Amboni M, Cereda E, Fabbri M, Adjei P, Akassi J, Bonetti A, Pezzoli G (2014) The modern pre-levodopa era of Parkinson’s disease: insights into motor complications from sub-Saharan Africa. Brain 137(Pt 10):2731–2742. https://doi.org/10.1093/brain/awu195

Article  PubMed  PubMed Central  Google Scholar 

GBD 2016 Neurology Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459–480. https://doi.org/10.1016/S1474-4422(18)30499-X

Article  Google Scholar 

GBD 2016 Parkinson’s Disease Collaborators (2018) Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):939–953. https://doi.org/10.1016/S1474-4422(18)30295-3

Article  Google Scholar 

De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER (2022) Preventing Parkinson’s Disease: An Environmental Agenda. J Parkinsons Dis 12(1):45–68. https://doi.org/10.3233/JPD-212922

Article  PubMed Central  Google Scholar 

Deb R, An S, Bhat G, Shill H, Ogras UY (2022) A Systematic Survey of Research Trends in Technology Usage for Parkinson’s Disease. Sensors (basel) 22:15. https://doi.org/10.3390/s22155491

Article  Google Scholar 

Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5):384–386. https://doi.org/10.1212/01.wnl.0000247740.47667.03

Article